Global major in patient-focused innovation for structural heart disease and critical care monitoring, Edwards Lifesciences Corporation EW is making.

There is currently no way to stop calcification of the aortic valve. If all else fails, the valve must be replaced. To better ...

MISSISSAUGA, Ontario, Jan. 25, 2018 /CNW/ -- Edwards Lifesciences Corporation, the global leader in patient-focused innovations for structural hea ...

Six months after aortic valve replacement, many people can return to typical activities like exercising, socializing, and working. However, the recovery timeline can vary from person to person.

The company’s most recent breakthrough, the Inspiris Resilia aortic valve, is constructed on the Perimount platform and features Resilia tissue and VFit technology. Inspiris stands as the ...

CAIRO, April 18, 2025--Edwards Lifesciences (NYSE: EW) today announced new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary RESILIA tissue ...

Lighting Rock Research Fri, Oct. 25, 2024. Edwards Lifesciences: ... It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; ...

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had an overall mortality rate of just 8.1% at one year, well below the ...

The Inspiris Resilia Aortic valve which is an artificial biological valve is also a tri-leaflet valve made from cow’s heart tissue and specially purified with special agents to resist or ...

Surgical valves are now being designed, he noted, with the prospect of future ViV TAVI. For example, the Inspiris Resilia aortic valve (Edwards Lifesciences) is designed with fluoroscopically visible ...

Today, RESILIA tissue is used in a wide range of Edwards’ surgical and transcatheter platforms, including the INSPIRIS RESILIA aortic surgical valve, the KONECT RESILIA aortic surgical valve ...